FindTrial
Sign In

The application and related research of Fluorescent tracer technology in the sentinel lymph node biopsy of early breast cancer

The application and related research of Fluorescent tracer technology in the sentinel lymph node biopsy of early breast cancer

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-DCD-15006532
Enrollment
Unknown
Registered
2015-06-08
Start date
2015-03-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast cancer

Interventions

Gold Standard:
Index test:

Sponsors

Affiliated Tumor Hospital of Xinjiang Medical University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
20 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. The patient's clinical stage is T1-2N0M0 at first; 2. The patient's clinical stage become T1-2N0M0 after neoadjuvant chemotherapy; 3. There is only one lesion,especially the patient who wants to keep the breast.

Exclusion criteria

Exclusion criteria: 1. The patient's axillary lymph node have ever been cutted; 2. The patient allergic to the tracer; 3. There are multiple lesions on the patient; 4. The patient was carried out radiation therapy to the axillary.

Design outcomes

Primary

MeasureTime frame
false negative rate;—

Countries

China

Contacts

Public ContactOu Jianghua
jianghuaou@hotmail.com+86 15160985670

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026